Citation Impact
Citing Papers
Myocardial Ischemia/Reperfusion Injury Is Mediated by Leukocytic Toll-Like Receptor-2 and Reduced by Systemic Administration of a Novel Anti–Toll-Like Receptor-2 Antibody
2009
Plasmacytoid Dendritic Cell Dynamics and Alpha Interferon Production during Simian Immunodeficiency Virus Infection with a Nonpathogenic Outcome
2008 StandoutNobel
Toll-Like Receptor-4 Modulates Survival by Induction of Left Ventricular Remodeling after Myocardial Infarction in Mice
2008
Resident Dendritic Cells Prevent Postischemic Acute Renal Failure by Help of Single Ig IL-1 Receptor-Related Protein
2009
Structure of the PAPP-ABP5 complex reveals mechanism of substrate recognition
2022 StandoutNobel
Bioinformatics for protein biomarker panel classification: what is needed to bring biomarker panels intoin vitrodiagnostics?
2009
S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling
2012
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
2012 Standout
Oxidative stress, aging, and diseases
2018 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Resistin, Adiponectin, and Risk of Heart Failure
2008
Mitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosis
2002
Ischaemia-induced up-regulation of Toll-like receptor 2 in circulating monocytes in cardiogenic shock
2011
Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice
2008
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
The Failing Heart — An Engine Out of Fuel
2007 Standout
TLR4 enhances TGF-β signaling and hepatic fibrosis
2007 Standout
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Pattern Recognition Receptors and Inflammation
2010 Standout
Rehospitalizations among Patients in the Medicare Fee-for-Service Program
2009 Standout
Toll-like receptors in systemic autoimmune disease
2006
Global prevalence of dementia: a Delphi consensus study
2005 Standout
Innate immune signaling in cardiac ischemia
2011
Intracellular Toll-like Receptors
2010 StandoutNobel
Statistical Models and Patient Predictors of Readmission for Heart Failure<subtitle>A Systematic Review</subtitle>
2008
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Does Accumulation of Advanced Glycation End Products Contribute to the Aging Phenotype?
2010
Troponin Elevation in Heart Failure
2010
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
2012 Standout
A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds
1993 StandoutNature
High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice
2008
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
pROC: an open-source package for R and S+ to analyze and compare ROC curves
2011 Standout
The immunology of stroke: from mechanisms to translation
2011 Standout
ATF3 Inhibits Doxorubicin-induced Apoptosis in Cardiac Myocytes: A Novel Cardioprotective Role of ATF3
2002
Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart
2008
Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury
2006
TOLL-LIKE RECEPTORS IN ISCHEMIA-REPERFUSION INJURY
2009
Third Universal Definition of Myocardial Infarction
2012 Standout
Recognition of Hyaluronan Released in Sterile Injury Involves a Unique Receptor Complex Dependent on Toll-like Receptor 4, CD44, and MD-2
2007 StandoutNobel
Developmental and regional expression in the rat brain and functional properties of four NMDA receptors
1994 StandoutNobel
Toll‐like receptors, endogenous ligands, and systemic autoimmune disease
2005
Toll-Like Receptor 2 Signaling in Response to Brain Injury: An Innate Bridge to Neuroinflammation
2006
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
1994 Standout
New and Emerging Biomarkers in Left Ventricular Systolic Dysfunction—Insight into Dilated Cardiomyopathy
2013
Developmental and abnormal cell death in C. Elegans
1992 StandoutNobel
Toll-like receptor signaling in endogenous neuroprotection and stroke
2008
The innate immune response in reperfused myocardium
2012
The molecular neurobiology of depression
2008 StandoutNature
Biomarkers in Heart Failure
2008 Standout
Frailty in elderly people
2013 Standout
The relationships among hyperuricemia, endothelial dysfunction, and cardiovascular diseases: Molecular mechanisms and clinical implications
2012
Preservation of Fertility in Patients with Cancer
2009 Standout
Tumor Necrosis Factor-α Promotes Macrophage-Induced Vascular Smooth Muscle Cell Apoptosis by Direct and Autocrine Mechanisms
2003
Oxidative damage and mitochondrial decay in aging.
1994 Standout
Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism
2006
Endogenous IRAK-M Attenuates Postinfarction Remodeling Through Effects on Macrophages and Fibroblasts
2012
Innate immunity mediates myocardial preconditioning through Toll-like receptor 2 and TIRAP-dependent signaling pathways
2010
Arterial Stiffness and Cardiovascular Events
2010 Standout
The Emerging Role of Innate Immunity in the Heart and Vascular System
2011
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Strain-Specific Manifestation of Lupus-like Systemic Autoimmunity Caused by Zap70 Mutation
2019 StandoutNobel
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
A Family of AMPA-Selective Glutamate Receptors
1990 StandoutScienceNobel
Doxorubicin Induces Apoptosis by Activation of Caspase-3 in Cultured Cardiomyocytes In Vitro and Rat Cardiac Ventricles In Vivo
2006
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio.
2002
Alternative splicing generates functionally distinct N-methyl-D-aspartate receptors.
1992 StandoutNobel
Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger
2008 StandoutNobel
Helium‐based cold atmospheric plasma‐induced reactive oxygen species‐mediated apoptotic pathway attenuated by platinum nanoparticles
2016
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits
2007
Temporal and Anatomic Relationship between Virus Replication and Cytokine Gene Expression after Vaginal Simian Immunodeficiency Virus Infection
2005
Modulation of Doxorubicin-Induced Cardiac Dysfunction in Toll-Like Receptor-2–Knockout Mice
2004
Targeted Deletion of Nuclear Factor κB p50 Enhances Cardiac Remodeling and Dysfunction Following Myocardial Infarction
2009
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
Novel markers for heart failure diagnosis and prognosis
2005
Deleterious Effect of the IL‐23/IL‐17A Axis and γδT Cells on Left Ventricular Remodeling After Myocardial Infarction
2012
Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium
2005
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
1993 StandoutScience
Analysis of Pregnancy-Associated Plasma Protein A Production in Human Adult Cardiac Progenitor Cells
2013
Neuropathology of Degenerative Cell Death inCaenorhabditis elegans
1997 StandoutNobel
The Cytolytic P 2Z Receptor for Extracellular ATP Identified as a P 2X Receptor (P2X 7 )
1996 StandoutScience
EAT-4, a Homolog of a Mammalian Sodium-Dependent Inorganic Phosphate Cotransporter, Is Necessary for Glutamatergic Neurotransmission inCaenorhabditis elegans
1999 StandoutNobel
Physiology of Microglia
2011 Standout
Toll-Like Receptors 2-Deficient Mice Are Protected Against Postischemic Coronary Endothelial Dysfunction
2007
Cutting Edge: TLR4 Activation Mediates Liver Ischemia/Reperfusion Inflammatory Response via IFN Regulatory Factor 3-Dependent MyD88-Independent Pathway
2004
Heteromeric NMDA Receptors: Molecular and Functional Distinction of Subtypes
1992 StandoutScienceNobel
Works of Joji Nitobe being referenced
Dynamic 123I‐BMIPP single‐photon emission computed tomography in patients with congestive heart failure: Effect of angiotensin ii type‐1 receptor blockade
2004
Dual response to Fas ligation in human endothelial cells: apoptosis and induction of chemokines, interleukin-8 and monocyte chemoattractant protein-1
2003
Serum Pregnancy-Associated Plasma Protein A in Patients With Heart Failure
2011
Heart-Type Fatty Acid-Binding Protein Is More Sensitive Than Troponin T to Detect the Ongoing Myocardial Damage in Chronic Heart Failure Patients
2007
Prognostic value of elevated circulating heart-type fatty acid binding protein in patients with congestive heart failure
2005
Apoptosis in Rat Cardiac Myocytes Induced by Fas Ligand: Priming for Fas-mediated Apoptosis with Doxorubicin
2000
Reactive oxygen species regulate FLICE inhibitory protein (FLIP) and susceptibility to Fas-mediated apoptosis in cardiac myocytes
2002
Angiotensin-converting enzyme inhibition improves cardiac fatty acid metabolism in patients with congestive heart failure
2003
High Serum Level of Pentosidine, an Advanced Glycation End Product (AGE), is a Risk Factor of Patients with Heart Failure
2007
Serum Resistin is Associated With High Risk in Patients With Congestive Heart Failure A Novel Link Between Metabolic Signals and Heart Failure
2007
Persistently Increased Serum Concentration of Heart-Type Fatty Acid-Binding Protein Predicts Adverse Clinical Outcomes in Patients With Chronic Heart Failure
2007
Risk Stratification of Chronic Heart Failure Patients by Multiple Biomarkers Implications of BNP, H-FABP, and PTX3
2008
Toll-Like Receptor-2 Modulates Ventricular Remodeling After Myocardial Infarction
2003
Hyperuricemia associated with high cardiac event rates in the elderly with chronic heart failure.
2006
Nitric Oxide Enhances Expression and Shedding of Tumor Necrosis Factor Receptor I (p55) in Endothelial Cells
2000